E-LIB Suche - Ergebnisse für: Kreisl, T. N.

1

AT-06 * A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PAT..:

Aregawi, D. ; Kreisl, T. N. ; Innis, E..
Neuro-Oncology. 16 (2014) suppl 5 - p. v9-v9 , 2014

Link: https://doi.org/10.1093/..

2

ET-30 * A PHASE I TRIAL OF AZD7451, A TROPOMYOSIN-RECEPTOR ..:

Kreisl, T. N. ; Peer, C. ; Brown, J...
Neuro-Oncology. 16 (2014) suppl 5 - p. v86-v86 , 2014

Link: https://doi.org/10.1093/..

3

A phase I/II trial of vandetanib for patients with recurren..:

Kreisl, T. N. ; McNeill, K. A. ; Sul, J....
Neuro-Oncology. 14 (2012) 12 - p. 1519-1526 , 2012

Link: https://doi.org/10.1093/..

4

A phase II trial of single-agent bevacizumab in patients wi..:

Kreisl, T. N. ; Zhang, W. ; Odia, Y....
Neuro-Oncology. 13 (2011) 10 - p. 1143-1150 , 2011

Link: https://doi.org/10.1093/..

5

Neuromuscular junction toxicity with tandutinib induces a m..:

Lehky, T.J. ; Iwamoto, F.M. ; Kreisl, T.N...
Neurology. 76 (2011) 3 - p. 236-241 , 2011

Link: https://doi.org/10.1212/..

6

Medical and Neuro-Oncology:

Barker, C. A. ; Chang, M. ; Lassman, A. B....
Neuro-Oncology. 12 (2010) Supplement 4 - p. iv36-iv57 , 2010

Link: https://doi.org/10.1093/..

7

ED-06 * BRAINSTEM GLIOMAS IN ADULTS: DO ADULT DIFFUSE INTRI..:

Garren, N. ; Harris, S. ; Baker, E...
Neuro-Oncology. 16 (2014) suppl 5 - p. v67-v67 , 2014

Link: https://doi.org/10.1093/..

8

Neuromuscular junction toxicity with tandutinib induces a m..:

Lehky, T.J ; Iwamoto, F.M ; Kreisl, T.N..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034397. , 2011

Link: http://www.ncbi.nlm.nih...

9

A Workshop on Cognitive Aging and Impairment in the 9/11-Ex..:

Daniels, RD ; Clouston, SAP ; Hall, CB...
https://discovery.ucl.ac.uk/id/eprint/10120684/1/ijerph-18-00681-v2.pdf. , 2021

Link: https://discovery.ucl.ac..

10

Comparison of amyloid burden in individuals with Down syndr..:

Boerwinkle, Anna H ; Gordon, Brian A ; Wisch, Julie...
qt2z42w6wc. , 2023

Link: https://escholarship.org..

11

Joint‐label fusion brain atlases for dementia research in D..:

Queder, Nazek ; Phelan, Michael J ; Taylor, Lisa...
qt3ks3d1gq. , 2022

Link: https://escholarship.org..

12

AT-04 * A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBIN..:

Ambady, P. ; Warren, K. ; Shih, J...
Neuro-Oncology. 16 (2014) suppl 5 - p. v8-v9 , 2014

Link: https://doi.org/10.1093/..

13

AT-03 * PHASE I TRIAL OF ENZASTAURIN (LY 317615) IN COMBINA..:

Ambady, P. ; Kreisl, T. ; Warren, K...
Neuro-Oncology. 16 (2014) suppl 5 - p. v8-v8 , 2014

Link: https://doi.org/10.1093/..

14

Causes of Death and End-of-Life Care in Patients With Intra..:

Barbaro, Marissa ; Blinderman, Craig D. ; Iwamoto, Fabio M....
Neurology. 98 (2022) 3 - p. , 2022

Link: https://doi.org/10.1212/..

15

A phase II trial of enzastaurin (LY317615) in combination w..:

Odia, Yazmin ; Iwamoto, Fabio M. ; Moustakas, Argirios...
Journal of Neuro-Oncology. 127 (2015) 1 - p. 127-135 , 2015

Link: https://doi.org/10.1007/..